IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
Eslam, Mohammed; Leung, Reynold; Romero-Gomez, Manuel; Mangia, Alessandra; Irving, William L; Sheridan, David; Spengler, Ulrich; Mollison, Lindsay; Cheng, Wendy; Bugianesi, Elisabetta; McLeod, Duncan; Zaitoun, Abed M; Attino, Vito; Goeltz, Diane; Nattermann, Jacob; Douglas, Mark; Booth, David R; George, Jacob; Ahlenstiel, Golo.
; 61(2): 235-41, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24768758
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies.
[FREQUENCY OF OCCURRENCE OF POLYMORPHIC VARIANTS OF IL28B GENE AND GENOTYPES OF HEPATITIS C VIRUS IN POPULATION OF YAKUTIA: CLINICAL OUTCOMES].
Correlation Study Between IL-28B Gene Polymorphism (rs8099917SNP) and Sustained Virological Response in Iranian Patients with Chronic Hepatitis C.
IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
Interferon λ3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.